JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M701613200 on May 24, 2007

J. Biol. Chem., Vol. 282, Issue 29, 21268-21277, July 20, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/29/21268    most recent
M701613200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xin, M.
Right arrow Articles by Deng, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xin, M.
Right arrow Articles by Deng, X.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Protein Kinase C{zeta} Abrogates the Proapoptotic Function of Bax through Phosphorylation*

Meiguo Xin, Fengqin Gao, W. Stratford May, Tammy Flagg, and Xingming Deng1

From the University of Florida Shands Cancer Center, Department of Medicine and Department of Anatomy and Cell Biology, University of Florida, Gainesville, Florida 32610-3633

Protein kinase C{zeta} (PKC{zeta}) is an atypical PKC isoform that plays an important role in supporting cell survival but the mechanism(s) involved is not fully understood. Bax is a major member of the Bcl-2 family that is required for apoptotic cell death. Because Bax is extensively co-expressed with PKC{zeta} in both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) cells, it is possible that Bax may act as the downstream target of PKC{zeta} in regulating survival and chemosensitivity of lung cancer cells. Here we discovered that treatment of cells with nicotine not only enhances PKC{zeta} activity but also results in Bax phosphorylation and prolonged cell survival, which is suppressed by a PKC{zeta} specific inhibitor (a myristoylated PKC{zeta} pseudosubstrate peptide). Purified, active PKC{zeta} directly phosphorylates Bax in vitro. Overexpression of wild type or the constitutively active A119D but not the dominant negative K281W PKC{zeta} mutant results in Bax phosphorylation at serine 184. PKC{zeta} co-localizes and interacts with Bax at the BH3 domain. Specific depletion of PKC{zeta} by RNA interference blocks nicotine-stimulated Bax phosphorylation and enhances apoptotic cell death. Intriguingly, forced expression of wild type or A119D but not K281W PKC{zeta} mutant results in accumulation of Bax in cytoplasm and prevents Bax from undergoing a conformational change with prolonged cell survival. Purified PKC{zeta} can directly dissociate Bax from isolated mitochondria of C2-ceramide-treated cells. Thus, PKC{zeta} may function as a physiological Bax kinase to directly phosphorylate and interact with Bax, which leads to sequestration of Bax in cytoplasm and abrogation of the proapoptotic function of Bax.


Received for publication, February 23, 2007 , and in revised form, May 22, 2007.

* This was supported by a Flight Attendant Medical Research Institute Clinical Innovator Award, NCI, National Institutes of Health Grant R01 CA112183 (to X. D.), and a National Institutes of Health T32 Training Grant in Cancer Biology (to M. X.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: 1376 Mowry Rd., Cancer/Genetics Research Complex, Rm. 262, P. O. Box 103633, Gainesville, FL 32610-3633. Fax: 352-273-8285; Tel.: 352-273-8170; E-mail: xdeng{at}ufl.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Li, C. Yu, Y. Han, H. Ren, W. Shi, C. Fu, D. He, L. Huang, C. Yang, X. Wang, et al.
Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2761 - H2768.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Defer, A. Azroyan, F. Pecker, and C. Pavoine
TNFR1 and TNFR2 Signaling Interplay in Cardiac Myocytes
J. Biol. Chem., December 7, 2007; 282(49): 35564 - 35573.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.